Access to hematopoietic stem cell transplantation: Effect of race and sex

Cancer

Volumn 116, Issue 14, 2010, Pages 3469-3476

  Joshua, Thomas V ^a   Rizzo, J Douglas ^b   Zhang, Mei Jie ^b   Hari, Parameswaran N ^b   Kurian, Seira ^c   Pasquini, Marcelo ^b   Majhail, Navneet S ^d   Lee, Stephanie J ^e   Horowitz, Mary M ^b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c LOS ANGELES COUNTY DEPARTMENT OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Access to care; Effect of race and sex; Hematopoietic stem cell transplantation; Leukemia; Lymphoma

Indexed keywords

ADOLESCENT; ADULT; AFRICAN AMERICAN; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER REGISTRY; CAUCASIAN; CHILD; DONOR; FEMALE; HEALTH CARE ACCESS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INCIDENCE; INFANT; LEUKEMIA; LOGISTIC REGRESSION ANALYSIS; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NEWBORN; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; SEX DIFFERENCE; UNRELATED DONOR;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; CHILD; CHILD, PRESCHOOL; CONTINENTAL POPULATION GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; INFANT, NEWBORN; LEUKEMIA; LYMPHOMA; MALE; MIDDLE AGED; MULTIPLE MYELOMA; SEX FACTORS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; UNITED STATES;

EID: 77954889709     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25297     Document Type: Article

References (34)

1. Serna DS, Lee SJ, Zhang MJ, et al. Trends in survival rates after allogeneic hematopoietic stem-cell transplantation for acute and chronic leukemia by ethnicity in the United States and Canada. J Clin Oncol. 2003;21:3754-3760.
2. Bach FH, Albertini RJ, Joo P, Anderson JL, Bortin MM. Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet. 1968;2:1364-1366.
3. Gatti RA, Meuwissen HJ, Allen HD, Hong R, Good RA. Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet. 1968;2:1366-1369.
4. Center for International Blood and Marrow Transplant Research. CIBMTR Progress Report: January-December 2007. Milwaukee, WI: Center for International Blood and Marrow Transplant Research; 2007:5.
5. Mandelblatt JS, Yabroff KR, Kerner JF. Equitable access to cancer services: a review of barriers to quality care. Cancer. 1999;86:2378-2390.
6. Mitchell JM, Meehan KR, Kong J, Schulman KA. Access to bone marrow transplantation for leukemia and lymphoma: the role of sociodemographic factors. J Clin Oncol. 1997;15:2644-2651. (Pubitemid 27289896)
7. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med. 2006;354:1813-1826.
8. Lennard AL, Jackson GH. Stem cell transplantation. BMJ. 2000;321:433-437.
9. Smedley BD, Stith AY, Nelson AR. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: National Academies Press; 2003.
10. Agency for Healthcare Research and Quality. National Healthcare Disparities Report. Rockville, MD: Agency for Healthcare Research and Quality; 2006.
11. Long JA, Chang VW, Ibrahim SA, Asch DA. Update on the health disparities literature. Ann Intern Med. 2004;141:805-812.
12. Shavers VL, Harlan LC, Stevens JL. Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer. 2003;97:134-147.
13. Demark-Wahnefried W, Strigo T, Catoe K, et al. Knowledge, beliefs, and prior screening behavior among blacks and whites reporting for prostate cancer screening. Urology. 1995;46:346-351.
14. Robinson KD, Kimmel EA, Yasko JM. Reaching out to the African American community through innovative strategies. Oncol Nurs Forum. 1995;22:1383-1391.
15. Vernon SW, Heckel V, Jackson GL. Medical outcomes of care for breast cancer among health maintenance organization and fee-for-service patients. Clin Cancer Res. 1995;1: 179-184.
16. Zaloznik AJ. Breast cancer stage at diagnosis: Caucasians versus Afro-Americans. Breast Cancer Res Treat. 1995;34: 195-198.
17. Mehta P, Pollock BH, Nugent M, Horowitz M, Wingard JR. Access to stem cell transplantation: do women fare as well as men? Am J Hematol. 2003;72:99-102.
18. Liu JR, Conaway M, Rodriguez GC, Soper JT, Clarke-Pearson DL, Berchuck A. Relationship between race and interval to treatment in endometrial cancer. Obstet Gynecol. 1995; 86(4 pt 1):486-490.
19. Schapira MM, McAuliffe TL, Nattinger AB. Treatment of localized prostate cancer in African-American compared with Caucasian men. Less use of aggressive therapy for comparable disease. Med Care. 1995;33:1079-1088.
20. King TE Jr, Brunetta P. Racial disparity in rates of surgery for lung cancer. N Engl J Med. 1999;341:1231-1233.
21. Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB. Survival of blacks and whites after a cancer diagnosis. JAMA. 2002;287:2106-2113.
22. Demark-Wahnefried W, Schildkraut JM, Iselin CE, et al. Treatment options, selection, and satisfaction among African American and white men with prostate carcinoma in North Carolina. Cancer. 1998;83:320-330.
23. Espey D, Paisano R, Cobb N. Regional patterns and trends in cancer mortality among American Indians and Alaska Natives, 1990-2001. Cancer. 2005;103:1045-1053.
24. Du W, Simon MS. Racial disparities in treatment and survival of women with stage I-III breast cancer at a large academic medical center in metropolitan Detroit. Breast Cancer Res Treat. 2005;91:243-248.
25. Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94: 334-357. (Pubitemid 34257478)
26. Asch DA, Armstrong K. Aggregating and partitioning populations in health care disparities research: differences in perspective. J Clin Oncol. 2007;25:2117-2121.
27. Surveillance, Epidemiology, and End Results (SEER) Program. Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995. In: Ries LAG, Gurney JG, Linet M, Tamra T, Young JL, Bunin GR, eds. NIH Pub. No 99-4649. Bethesda, MD: National Cancer Institute; 1999.
28. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat (6.4) Database: Incidence-SEER 9 Regs Public-Use, Nov 2004 Sub (1973-2002). Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch; released April 2005, based on the November 2004 submission. Available at: www.seer. cancer.gov.
29. US Census Bureau. Race and Gender Data. Available at: http://www.census.gov 2000. Accessed June 11, 2005.
30. Nietfeld JJ, Pasquini MC, Logan BR, Verter F, Horowitz MM. Lifetime probabilities of hematopoietic stem cell transplantation in the U.S. Biol Blood Marrow Transplant. 2008;14:316-322.
31. Pasquini M. Current use and outcome of hematopoietic stem cell transplantation: part I - CIBMTR Summary Slides, 2005. CIBMTR Newsletter [serial online]. 2005;12: 5-8.
32. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999-2005. Incidence and Mortality Webbased Report. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2009. Available at: www.cdc.gov/uscs. Accessed June 11, 2005.
33. North American Association of Central Cancer Registries, Inc. Average-Annual Registry-Specific Cancer Incidence by Race, Ethnicity, and Sex; 2009v2. Springfield, IL: North American Association of Central Cancer Registries, Inc; Year. Available at: http://www.naaccr.org/filesystem/pdf/ CINA2009v2.world.pdf. Accessed January 17, 2009.
34. Parker SL, Johnston Davis K, Wingo PA, Ries LAG, Heath CW. Cancer statistics by race and ethnicity. CA Cancer J Clin. 1998;48:31-48. Available at: http://caonline.amcancersoc.org/cgi/reprint/48/1/31.pdf. Accessed January 17, 2009.